Pcv42 - A Pharmacoeconomic Analysis of the Use of Apixaban for the Prevention of Stroke and Systemic Embolism in Russian Patients With Non-Valvular Atrial Fibrillation

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.589
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV